OP.T
OPPOSITION TERMINATED NO. 999999
24/05/2023
Voltar para busca
Dado oficial do USPTO
AVACARE CLINICAL RESEARCH NETWORK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
08/07/2023
Tipo de marca
Mista
Classes Nice
35, 42
Data de depósito
18/11/2019
Data de registro
16/05/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/05/2023
Última transação
08/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2020-02-00
Primeiro uso no comércio
2020-02-00
Código do desenho
3
Tipo de titular
03
Localização do titular
Durham, NC
Examinador
PINO, BRIAN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the term "AVACARE" in stylized letters, beginning with a capital letter "A" in which the horizontal element of the letter is formed from left to right by three circles of increasing size, a slightly larger oval, and a short line that becomes the top of the following lower case letter "V" in the following lowercase letter string "VACARE," which appears above the terms "CLINICAL RESEARCH NETWORK" centered thereunder in smaller uppercase font, all of which elements are in the color seafoam green.
Titulares e representantes
Titulares
QCare Site Services, Inc.
Representantes
ARLENE D HANKS MOORE & VAN ALLEN PLLC
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Site management organization servicesbusiness assistance services for other clinical research organizationsnew trial and study procurementbudgeting and contractingbusiness study feasibilitiescreation and implementation of standard operating proceduresproviding and managing study coordinators; development of comprehensive patient recruitment strategies; overseeing informed consent administration and managementbusiness administration and business management assistance for others; patient referral managementbusiness administration and business management assistance for others; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trialsapplications for drug approval and late phase and/or real world research studies; business data compilation and tracking services for othersinteractive tracking of clinical trial subject enrollmentstatus and adverse side effects of treatment and medicationincluding interactive services on mobile platform; business consulting servicesconsulting regarding regulatory inspections and biopharmaceutical and biotechnology audits
Classe 42
Medical and scientific researchconducting clinical trials and translational research for others; clinical research services during clinical trials of pharmaceuticals and medical devicesdata collection service using software to evaluateanalyzecollect clinical data; multitherapeutic site management organization servicesresearch and development services in the field of pharmaceuticals and drug development
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
OP.D
OPPOSITION DISMISSED NO. 999999
24/05/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
16/05/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/04/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/04/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/03/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/03/2023
IUAF
USE AMENDMENT FILED
10/03/2023
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13/09/2022
OP.I
OPPOSITION INSTITUTED NO. 999999
05/06/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2020
PUBO
PUBLISHED FOR OPPOSITION
07/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/03/2020
ALIE
ASSIGNED TO LIE
05/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
27/02/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/02/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
27/02/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/02/2020
DOCK
ASSIGNED TO EXAMINER
21/02/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
26/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/11/2019
NWAP
NEW APPLICATION ENTERED
21/11/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVACARE CLINICAL RESEARCH NETWORK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.